![Kevin Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Shaw
Generell Rådgivare på
NEXTCURE, INC.
Profil
Kevin G.
Shaw is Senior Vice President & General Counsel at NextCure, Inc. since 2023.
Previously, Mr. Shaw was Vice President & Deputy General Counsel at Precigen, Inc. from 2012 to 2022.
Education includes undergraduate studies at the University of Pennsylvania and graduate studies at George Washington University Law School.
Aktiva positioner av Kevin Shaw
| Företag | Position | Start |
|---|---|---|
| NEXTCURE, INC. | Generell Rådgivare | 2022-05-01 |
Tidigare kända positioner av Kevin Shaw
| Företag | Position | Slut |
|---|---|---|
| PRECIGEN, INC. | Företagsledare/Principal | 2022-05-01 |
Kevin Shaws utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
60
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University Law School
 George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
